142 related articles for article (PubMed ID: 37720214)
1. A serum metabolic biomarker panel for early rheumatoid arthritis.
Rodríguez-Muguruza S; Altuna-Coy A; Arreaza-Gil V; Mendieta-Homs M; Castro-Oreiro S; Poveda-Elices MJ; Del Castillo-Piñol N; Fontova-Garrofé R; Chacón MR
Front Immunol; 2023; 14():1253913. PubMed ID: 37720214
[TBL] [Abstract][Full Text] [Related]
2. Biomarker identification and pathway analysis of rheumatoid arthritis based on metabolomics in combination with ingenuity pathway analysis.
He Z; Liu Z; Gong L
Proteomics; 2021 Jun; 21(11-12):e2100037. PubMed ID: 33969925
[TBL] [Abstract][Full Text] [Related]
3. LC-MS-based serum metabolomics reveals a distinctive signature in patients with rheumatoid arthritis.
Li J; Che N; Xu L; Zhang Q; Wang Q; Tan W; Zhang M
Clin Rheumatol; 2018 Jun; 37(6):1493-1502. PubMed ID: 29442259
[TBL] [Abstract][Full Text] [Related]
4. Early Breast Cancer Detection Using Untargeted and Targeted Metabolomics.
Wei Y; Jasbi P; Shi X; Turner C; Hrovat J; Liu L; Rabena Y; Porter P; Gu H
J Proteome Res; 2021 Jun; 20(6):3124-3133. PubMed ID: 34033488
[TBL] [Abstract][Full Text] [Related]
5. [Differential metabolites and metabolic pathways involving acupuncture-induced improvement of rheumatoid arthritis patients based on gas chromatography-mass spectrometry].
Guo YG; Sun GW; Yang L; Li C; Yang J
Zhen Ci Yan Jiu; 2021 Feb; 46(2):145-51. PubMed ID: 33788436
[TBL] [Abstract][Full Text] [Related]
6. A discovery of screening markers for rheumatoid arthritis by liquid chromatography mass spectrometry: A metabolomic approach.
Lee YJ; Mun S; Lee YR; Lee S; Kwon S; Kim D; Lim MK; Kang HG; Lee J
Int J Rheum Dis; 2020 Oct; 23(10):1353-1362. PubMed ID: 32845094
[TBL] [Abstract][Full Text] [Related]
7. Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis.
Kim S; Hwang J; Xuan J; Jung YH; Cha HS; Kim KH
PLoS One; 2014; 9(6):e97501. PubMed ID: 24887281
[TBL] [Abstract][Full Text] [Related]
8. A Serum Biomarker Panel of exomiR-451a, exomiR-25-3p and Soluble TWEAK for Early Diagnosis of Rheumatoid Arthritis.
Rodríguez-Muguruza S; Altuna-Coy A; Castro-Oreiro S; Poveda-Elices MJ; Fontova-Garrofé R; Chacón MR
Front Immunol; 2021; 12():790880. PubMed ID: 34868079
[TBL] [Abstract][Full Text] [Related]
9. Serum 14-3-3η Could Improve the Diagnostic Rate of Rheumatoid Arthritis and Correlates to Disease Activity.
Guan SZ; Yang YQ; Bai X; Wang Y; Feng KQ; Zhang HJ; Dong M; Yang HW; Li HQ
Ann Clin Lab Sci; 2019 Jan; 49(1):57-62. PubMed ID: 30814078
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic properties of metabolic perturbations in rheumatoid arthritis.
Madsen RK; Lundstedt T; Gabrielsson J; Sennbro CJ; Alenius GM; Moritz T; Rantapää-Dahlqvist S; Trygg J
Arthritis Res Ther; 2011 Feb; 13(1):R19. PubMed ID: 21303541
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Serum Protein 14-3-3η (Eta) as a Novel Biomarker for Rheumatoid Arthritis.
El-Sherif WT; Nigm DA; Abd-Elsamea MH; Kassem AM
Egypt J Immunol; 2019 Jan; 26(1):163-175. PubMed ID: 31333006
[TBL] [Abstract][Full Text] [Related]
12. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
Shang X; Zhong X; Tian X
Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
[TBL] [Abstract][Full Text] [Related]
13. Combining Calcitonin and Procalcitonin and Rheumatoid Arthritis-Related Biomarkers Improve Diagnostic Outcomes in Early Rheumatoid Arthritis.
Liu Y; Shi J; Wang B; Zhou L; Zhou X; Du Y; Li D; Duan L; Hu Q; Chen W; Li P
Dis Markers; 2021; 2021():6331994. PubMed ID: 34136020
[TBL] [Abstract][Full Text] [Related]
14. [Integrated analysis of serum untargeted metabolomics and targeted bile acid metabolomics for identification of diagnostic biomarkers for colorectal cancer].
Wang X; Zhu Y; Zhou H; Huang Z; Chen H; Zhang J; Yang S; Chen G; Zhang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):443-453. PubMed ID: 37087590
[TBL] [Abstract][Full Text] [Related]
15. Urinary metabolomic biomarker candidates for skeletal muscle wasting in patients with rheumatoid arthritis.
Oliveira MS; Santo RCE; Silva JMS; Alabarse PVG; Brenol CV; Young SP; Xavier RM
J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1657-1669. PubMed ID: 37243418
[TBL] [Abstract][Full Text] [Related]
16. CTHRC1: A New Candidate Biomarker for Improved Rheumatoid Arthritis Diagnosis.
Myngbay A; Bexeitov Y; Adilbayeva A; Assylbekov Z; Yevstratenko BP; Aitzhanova RM; Matkarimov B; Adarichev VA; Kunz J
Front Immunol; 2019; 10():1353. PubMed ID: 31249576
[No Abstract] [Full Text] [Related]
17. Serum amino acid metabolic profiles of ankylosing spondylitis by targeted metabolomics analysis.
Zhou Y; Zhang X; Chen R; Han S; Liu Y; Liu X; Gao M; Yang C; Lu D; Sun B; Chen H
Clin Rheumatol; 2020 Aug; 39(8):2325-2336. PubMed ID: 32130577
[TBL] [Abstract][Full Text] [Related]
18. Serum biomarker panel for the diagnosis of rheumatoid arthritis.
Mun S; Lee J; Park M; Shin J; Lim MK; Kang HG
Arthritis Res Ther; 2021 Jan; 23(1):31. PubMed ID: 33461622
[TBL] [Abstract][Full Text] [Related]
19. Serum connective tissue growth factor is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis.
Yang X; Lin K; Ni S; Wang J; Tian Q; Chen H; Brown MA; Zheng K; Zhai W; Sun L; Jin S; Wang J
Arthritis Res Ther; 2017 Nov; 19(1):257. PubMed ID: 29166915
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers identified by serum metabolomic analysis to predict biologic treatment response in rheumatoid arthritis patients.
Takahashi S; Saegusa J; Onishi A; Morinobu A
Rheumatology (Oxford); 2019 Dec; 58(12):2153-2161. PubMed ID: 31143951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
